Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $153,972 - $205,992
260 New
260 $202,000
Q1 2020

Apr 28, 2020

SELL
$119.05 - $147.35 $29,167 - $36,100
-245 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $26,195 - $32,445
245 New
245 $34,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Capital Wealth Alliance, LLC Portfolio

Follow Capital Wealth Alliance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Wealth Alliance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Wealth Alliance, LLC with notifications on news.